Andy Surinach, MPH

Senior Director, Evidence Strategy
Genesis Research, NJ, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Alternative Approaches to Defining COVID-Related Inpatient Encounters in IBM® Marketscan® Data

  Saturday, August 27, 2022
  4:15 PM – 4:30 PM CEST

• Use of the New ICD-10-CM Diagnosis Code for Post COVID-19 Condition in Routine Clinical Practice in the United States

  Saturday, August 27, 2022
  4:30 PM – 4:45 PM CEST